Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19

Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19

Abstract COVID‐19 is associated with mitochondrial dysfunction and metabolic abnormalities, including the deficiencies in nicotinamide adenine dinucleotide (NAD+) and glutathione metabolism. Here it is investigated if administration of a mixture of combined metabolic activators (CMAs) consisting of...

Full description

Bibliographic Details
Main Authors: Ozlem Altay, Muhammad Arif, Xiangyu Li, Hong Yang, Mehtap Aydın, Gizem Alkurt, Woonghee Kim, Dogukan Akyol, Cheng Zhang, Gizem Dinler‐Doganay, Hasan Turkez, Saeed Shoaie, Jens Nielsen, Jan Borén, Oktay Olmuscelik, Levent Doganay, Mathias Uhlén, Adil Mardinoglu
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Advanced Science
Subjects:
combined metabolic activators
COVID‐19
metabolomics
omics data
proteomics
Online Access:https://doi.org/10.1002/advs.202101222

Internet

https://doi.org/10.1002/advs.202101222

Similar Items